This study elucidated the mechanisms of substrate stiffness-induced NEAT1 regulation of the EMT process through activating the WNT/β-catenin pathway in HepG2 cells, suggesting that the NEAT1-WNT/β-catenin pathway may potentially serve as a target for the clinical therapy of liver cancer. The gene discussed is NEAT1; the disease is liver cancer.